MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, DVA had -$122,078K decrease in cash & cash equivalents over the period. $1,310,636K in free cash flow.

Cash Flow Overview

Change in Cash
-$122,078K
Free Cash flow
$1,310,636K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-12-31
2024-12-31
2023-12-31
2022-12-31
Net income
1,078,716 1,250,737 956,978 781,643
Depreciation and amortization
715,348 723,860 745,443 732,602
Impairment charges
0 0 26,083 -
Loss on extinguishment of debt
12,386 12,527 7,132 -
Stock-based compensation expense
139,953 102,788 112,375 95,427
Deferred income taxes
86,574 -57,840 -39,354 -75,669
Equity investment loss, net
-134,313 -115,839 -64,777 -8,773
Loss on sales of business interests, net
---0
Gain on changes in ownership interests
0 109,466 --
Other non-cash (gains) and losses, net
17,549 -13,414 8,938 -21,693
Accounts receivable
210,632 29,766 -172,361 148,394
Inventories
19,950 -17,942 32,132 757
Other current assets
124,297 -36,801 43,437 -27,533
Other long-term assets
40,253 67,031 5,792 50,549
Accounts payable
128,303 1,699 26,890 87,481
Accrued compensation and benefits
-24,042 14,687 56,209 34,536
Other current liabilities
-29,963 46,733 27,082 89,955
Income taxes
50,245 -44,214 1,570 -24,103
Other long-term liabilities
7,348 -6,672 -8,216 -15,601
Net cash provided by (used in) operating activities, total
1,886,500 2,022,038 2,059,031 1,564,570
Additions of property and equipment
575,864 555,443 567,985 603,429
Acquisitions
117,468 246,068 26,394 57,308
Proceeds from asset and business sales
34,173 25,862 30,610 117,582
Purchase of debt investments held-to-maturity
16,405 15,319 37,180 129,803
Purchase of other debt and equity investments
6,031 9,140 9,566 3,590
Proceeds from debt investments held-to-maturity
45,413 22,638 99,639 71,125
Proceeds from sale of other debt and equity investments
6,723 4,566 10,365 3,781
Purchase of equity method investments
27,030 5,205 276,202 31,885
Distributions from equity method investments
1,540 6,680 4,913 3,962
Payments to acquire other investments
-0 0 782
Net cash provided by (used in) investing activities, total
-654,949 -771,429 -771,800 -630,347
Borrowings
5,612,280 6,624,310 2,468,341 2,393,116
Payments on long-term debt
4,788,845 5,515,213 3,020,956 2,404,395
Deferred and debt related financing costs
53,819 50,874 69,791 3
Purchase of treasury stock from related party
484,633 ---
Purchase of treasury stock
1,308,366 1,385,932 272,219 802,228
Distributions to noncontrolling interests
324,270 337,042 280,938 267,946
Net proceeds from issuance of common stock under employee stock plans
23,290 20,453 --
Net (payments) receipts related to stock purchases and awards
--48,112 37,367
Payment, tax withholding, share-based payment arrangement
35,291 134,040 --
Contributions from noncontrolling interests
7,078 14,499 14,773 14,797
Proceeds from sales of additional noncontrolling interests
3,794 860 50,962 3,673
Purchases of noncontrolling interests
25,998 53,958 12,555 20,775
Net cash used in financing activities
-1,374,780 -816,937 -1,170,495 -1,121,128
Effect of exchange rate changes on cash, cash equivalents and restricted cash
21,151 -18,481 8,909 -29,066
Less net increase (decrease) in cash, cash equivalents and restricted cash
-122,078 415,191 125,645 -215,971
Cash and cash equivalents at beginning of period
879,825 464,634 338,989 554,960
Cash and cash equivalents at end of period
757,747 879,825 464,634 338,989
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Davita_Kidney_Care-svg

DAVITA INC. (DVA)

Davita_Kidney_Care-svg

DAVITA INC. (DVA)